APA (7th ed.) Citation

Peine, B. R., Callaghan, M. U., Callaghan, J. H., & Glaros, A. K. (2022). Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis. Journal of Clinical Medicine, 11(12), 3491. https://doi.org/10.3390/jcm11123491

Chicago Style (17th ed.) Citation

Peine, Brian R., Michael U. Callaghan, Joseph H. Callaghan, and Alexander K. Glaros. "Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis." Journal of Clinical Medicine 11, no. 12 (2022): 3491. https://doi.org/10.3390/jcm11123491.

MLA (9th ed.) Citation

Peine, Brian R., et al. "Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis." Journal of Clinical Medicine, vol. 11, no. 12, 2022, p. 3491, https://doi.org/10.3390/jcm11123491.